Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Niraparib (commonly known by the brand name Zejula) is a prescription oral medication classified as a PARP inhibitor, used primarily as maintenance treatment for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer
Niraparib (commonly known by the brand name Zejula) is a prescription oral medication classified as a PARP inhibitor, used primarily as maintenance treatment for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer